Arkadiusz Surażyński

2.6k total citations
105 papers, 2.2k citations indexed

About

Arkadiusz Surażyński is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Arkadiusz Surażyński has authored 105 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Molecular Biology, 41 papers in Oncology and 29 papers in Cancer Research. Recurrent topics in Arkadiusz Surażyński's work include Peptidase Inhibition and Analysis (30 papers), Protease and Inhibitor Mechanisms (19 papers) and Cell Adhesion Molecules Research (16 papers). Arkadiusz Surażyński is often cited by papers focused on Peptidase Inhibition and Analysis (30 papers), Protease and Inhibitor Mechanisms (19 papers) and Cell Adhesion Molecules Research (16 papers). Arkadiusz Surażyński collaborates with scholars based in Poland, United States and China. Arkadiusz Surażyński's co-authors include Jerzy Pałka, James M. Phang, Wojciech Miltyk, Gregory L. Borchert, Ewa Karna, Sławomir Wołczyński, Yongmin Liu, Krzysztof Bielawski, Anna Bielawska and Ilona Zaręba and has published in prestigious journals such as SHILAP Revista de lepidopterología, Oncogene and International Journal of Molecular Sciences.

In The Last Decade

Arkadiusz Surażyński

98 papers receiving 2.2k citations

Peers

Arkadiusz Surażyński
In‐Chul Park South Korea
Eri S. Srivatsan United States
Min Lü China
Sungkwan An South Korea
Qiong Shi China
Joyce E. Rundhaug United States
Baskaran Govindarajan United States
Young‐Seuk Bae South Korea
Arkadiusz Surażyński
Citations per year, relative to Arkadiusz Surażyński Arkadiusz Surażyński (= 1×) peers Jerzy Pałka

Countries citing papers authored by Arkadiusz Surażyński

Since Specialization
Citations

This map shows the geographic impact of Arkadiusz Surażyński's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arkadiusz Surażyński with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arkadiusz Surażyński more than expected).

Fields of papers citing papers by Arkadiusz Surażyński

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arkadiusz Surażyński. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arkadiusz Surażyński. The network helps show where Arkadiusz Surażyński may publish in the future.

Co-authorship network of co-authors of Arkadiusz Surażyński

This figure shows the co-authorship network connecting the top 25 collaborators of Arkadiusz Surażyński. A scholar is included among the top collaborators of Arkadiusz Surażyński based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arkadiusz Surażyński. Arkadiusz Surażyński is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jakimiuk, Katarzyna, Łukasz Szoka, Arkadiusz Surażyński, & Michał Tomczyk. (2025). Anticancer Effect of Selected Flavonoids on Tongue Squamous Cell Carcinoma (SCC-25): In Vitro Study. Acta Poloniae Pharmaceutica - Drug Research. 82(1). 79–89.
3.
Kałafut, Joanna, Krystyna Kowalczuk, Arkadiusz Surażyński, et al.. (2025). MM-129 Counteracts 5-Fluorouracil-Induced Cellular Senescence in Colon Cancer via SIRT1/STAT3 Signaling Pathway. Cells. 14(19). 1498–1498.
6.
Wroński, Adam, Iwona Jarocka-Karpowicz, Arkadiusz Surażyński, et al.. (2024). Modulation of Redox and Inflammatory Signaling in Human Skin Cells Using Phytocannabinoids Applied after UVA Irradiation: In Vitro Studies. Cells. 13(11). 965–965. 4 indexed citations
7.
Radomska, Dominika, Robert Czarnomysy, Anna Szymanowska, et al.. (2024). Di- and Triselenoesters—Promising Drug Candidates for the Future Therapy of Triple-Negative Breast Cancer. International Journal of Molecular Sciences. 25(14). 7764–7764. 2 indexed citations
8.
Rzepka, Zuzanna, Justyna Magdalena Hermanowicz, Ewa Bębenek, et al.. (2024). Assessment of the Lipophilicity of Indole Derivatives of Betulin and Their Toxicity in a Zebrafish Model. Molecules. 29(18). 4408–4408. 1 indexed citations
9.
Bębenek, Ewa, Zuzanna Rzepka, Justyna Magdalena Hermanowicz, et al.. (2024). Synthesis, Pharmacokinetic Profile, Anticancer Activity and Toxicity of the New Amides of Betulonic Acid—In Silico and In Vitro Study. International Journal of Molecular Sciences. 25(8). 4517–4517. 6 indexed citations
10.
Biernacki, Michał, Tiago Conde, Arkadiusz Surażyński, et al.. (2023). Restorative Effect of Microalgae Nannochloropsis oceanica Lipid Extract on Phospholipid Metabolism in Keratinocytes Exposed to UVB Radiation. International Journal of Molecular Sciences. 24(18). 14323–14323. 12 indexed citations
11.
Hermanowicz, Justyna Magdalena, Robert Czarnomysy, Arkadiusz Surażyński, et al.. (2023). Assessment of an Anticancer Effect of the Simultaneous Administration of MM-129 and Indoximod in the Colorectal Cancer Model. Cancers. 16(1). 122–122. 2 indexed citations
12.
Pałka, Jerzy, et al.. (2023). Protective Effect of Amaranthus cruentus L. Seed Oil on UVA-Radiation-Induced Apoptosis in Human Skin Fibroblasts. International Journal of Molecular Sciences. 24(13). 10795–10795. 2 indexed citations
13.
Pałka, Jerzy, et al.. (2022). Nonsteroidal Anti-Inflammatory Drugs as PPARγ Agonists Can Induce PRODH/POX-Dependent Apoptosis in Breast Cancer Cells: New Alternative Pathway in NSAID-Induced Apoptosis. International Journal of Molecular Sciences. 23(3). 1510–1510. 14 indexed citations
14.
Pałka, Jerzy, et al.. (2022). NSAIDs Induce Proline Dehydrogenase/Proline Oxidase-Dependent and Independent Apoptosis in MCF7 Breast Cancer Cells. International Journal of Molecular Sciences. 23(7). 3813–3813. 7 indexed citations
15.
Hermanowicz, Justyna Magdalena, Krystyna Pawlak, Robert Czarnomysy, et al.. (2021). MM-129 as a Novel Inhibitor Targeting PI3K/AKT/mTOR and PD-L1 in Colorectal Cancer. Cancers. 13(13). 3203–3203. 14 indexed citations
16.
Pałka, Jerzy, et al.. (2021). P5C as an Interface of Proline Interconvertible Amino Acids and Its Role in Regulation of Cell Survival and Apoptosis. International Journal of Molecular Sciences. 22(21). 11763–11763. 30 indexed citations
17.
Surażyński, Arkadiusz, et al.. (2021). Proline oxidase silencing inhibits p53-dependent apoptosis in MCF-7 breast cancer cells. Amino Acids. 53(12). 1943–1956. 7 indexed citations
18.
Sadowska, Anna, Diana Sawicka, Katarzyna Niemirowicz-Laskowska, et al.. (2020). Heterobasidion annosum Induces Apoptosis in DLD-1 Cells and Decreases Colon Cancer Growth in In Vivo Model. International Journal of Molecular Sciences. 21(10). 3447–3447. 11 indexed citations
19.
Zaręba, Ilona, et al.. (2017). Methylparaben‐induced decrease in collagen production and viability of cultured human dermal fibroblasts. Journal of Applied Toxicology. 37(9). 1117–1124. 17 indexed citations
20.
Surażyński, Arkadiusz, et al.. (1968). Amino acid composition and biological protein value of whey yeasts.. Milk science international/Milchwissenschaft. 23. 484–486. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026